CD19-eiwit (C-human IgG1-Fc & AVI, menselijk)

CD19

B4, CVID3

C-human IgG1-Fc & AVI

< 1.0 EU per μg protein as determined by the LAL method.

≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC.

1.Immobilized Anti-CD19 Antibody Human IgG1 (Inebilizumab) at 2 μg/mL (100 μL/well) can bind Recombinant Human CD19 Protein (Fc & AVI Tag), Biotinylated (Cat: 11880-H41H-B), the EC50 is 15-45 ng/mL (QC tested) . 2.Immobilized Recombinant Human CD19 Protein (hFc & AVI Tag), Biotinylated, HPLC-verified (Cat: 11880-H41H-B) at 1 μg/mL (100 μl/well) on streptavidin precoated (5 μg/mL, 100 μL/well) can bind Inebilizumab derived Anti-CD19 Antibody , Human IgG1, the EC50 is 4.6-13.8 ng/mL (Routinely tested) .

Met1-Lys291

The recombinant Human CD19 consists of 525 amino acids and predicts a molecular mass of 58.65 kDa. It migrates as an approximately 68.8 kDa and 48.1 kDa band in SDS-PAGE under reducing conditions.

Human